- Home
- Publications
- Publication Search
- Publication Details
Title
Is the GAIN Act a turning point in new antibiotic discovery?
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF MICROBIOLOGY
Volume 59, Issue 3, Pages 153-156
Publisher
Canadian Science Publishing
Online
2013-02-06
DOI
10.1139/cjm-2013-0089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Validation of Thymidylate Kinase (TMK) with a Rationally Designed, Selective Antibacterial Compound
- (2012) Thomas A. Keating et al. ACS Chemical Biology
- Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
- (2012) Maya A. Farha et al. ACS Chemical Biology
- White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
- (2012) CLINICAL INFECTIOUS DISEASES
- Multitarget ligands in antibacterial research: progress and opportunities
- (2012) Stephen P East et al. Expert Opinion on Drug Discovery
- Europe to boost development of new antimicrobial drugs
- (2012) Tony Kirby LANCET
- Molecular mechanisms of antibiotic resistance
- (2011) Gerard D. Wright CHEMICAL COMMUNICATIONS
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Discovery research: the scientific challenge of finding new antibiotics
- (2011) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The crisis of no new antibiotics—what is the way forward?
- (2011) Laura JV Piddock LANCET INFECTIOUS DISEASES
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors
- (2011) J. B. Parsons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- The antibiotics market
- (2010) Bashar Hamad NATURE REVIEWS DRUG DISCOVERY
- The Genetic Landscape of a Cell
- (2010) M. Costanzo et al. SCIENCE
- Probing Teichoic Acid Genetics with Bioactive Molecules Reveals New Interactions among Diverse Processes in Bacterial Cell Wall Biogenesis
- (2009) Michael A. D'Elia et al. CHEMISTRY & BIOLOGY
- New screens and targets in antibacterial drug discovery
- (2009) Shannon B Falconer et al. CURRENT OPINION IN MICROBIOLOGY
- Are essential genes really essential?
- (2009) Michael A. D’Elia et al. TRENDS IN MICROBIOLOGY
- Epidemiology of Methicillin‐ResistantStaphylococcus aureus
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
- (2008) M. E. Hillenmeyer et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started